Olmesartan Medoxomil NDC 67877-447

Product information

Brand name (proprietary)

Olmesartan Medoxomil

Generic name (nonproprietary)

olmesartan medoxomil

Active ingredients

Olmesartan medoxomil — 40 mg/1

Dosage form

Tablet, Coated

Route

Oral

Labeler

Ascend Laboratories, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 206763

Marketing start

Apr 24, 2017

Listing expires

Dec 31, 2026

Other FDA classes

Angiotensin 2 Receptor Antagonists (Mechanism)

Identifiers

Product ID 67877-447_a1d66aa9-d0fa-4d21-bba0-ff8078c2e5afSPL ID a1d66aa9-d0fa-4d21-bba0-ff8078c2e5afSPL set ID 142b735a-e1cd-46e1-a523-3ef061001bf9RxCUI 349373, 349401, 349405UNII 6M97XTV3HDUPC 0367877445304

Pharmacologic class

Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877044705 followed by a unit qualifier and the quantity Copy

Package 67877-0447-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 206763

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.